Home > Journals > Minerva Gastroenterologica e Dietologica > Past Issues > Minerva Gastroenterologica e Dietologica 2006 September;52(3) > Minerva Gastroenterologica e Dietologica 2006 September;52(3):293-301

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA GASTROENTEROLOGICA E DIETOLOGICA

A Journal on Gastroenterology, Nutrition and Dietetics


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

REVIEWS  


Minerva Gastroenterologica e Dietologica 2006 September;52(3):293-301

language: English, Italian

The therapeutic role of thalidomide in inflammatory bowel disease

Casella G., De Marco E., Monti C., Baldini V.

1 Department of Medicine Desio Hospital, Desio, Milan, Italy
2 Department of Medicine Polyclinic of Monza, Monza, Milan, Italy


PDF  


Recent clinical experience with the use of thalidomide in inflammatory bowel disease is the focus of this article. Although widely used in Crohn’s disease, thalidomide therapy in patients with ulcerative colitis, children with Crohn’s disease, as well as patients with Crohn’s disease associated with upper gastrointestinal and genital tract involvement have been occasionally reported.

top of page

Publication History

Cite this article as

Corresponding author e-mail